FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046987218> ?p ?o ?g. }

• W2046987218 endingPage "744" @default.
• W2046987218 startingPage "737" @default.
• W2046987218 abstract "The ideal therapy for differentiated thyroid cancer is uncertain. Although thyroid hormone treatment is pivotal, the degree of thyrotropin (TSH) suppression that is required to prevent recurrences has not been studied in detail. We have examined the relation of TSH suppression to baseline disease characteristics and to the likelihood of disease progression in a cohort of thyroid cancer patients who have been followed in a multicenter thyroid cancer registry that was established in 1986. The present study describes 617 patients with papillary and 66 patients with follicular thyroid cancer followed annually for a median of 4.5 years (range 1–8.6 years). Cancer staging was assessed using a staging scheme developed and validated by the registry. Cancer status was defined as no residual disease; progressive disease at any follow-up time; or death from thyroid cancer. A mean TSH score was calculated for each patient by averaging all available TSH determinations, where 1 = undetectable TSH; 2 = subnormal TSH; 3 = normal TSH; and 4 = elevated TSH. Patients were also grouped by their TSH scores: group 1: mean TSH score 1.0–1.99; group 2: mean TSH score 2.0–2.99; group 3: mean TSH score 3.0–4.0. The degree of TSH suppression did not differ between papillary and follicular thyroid cancer patients. However, TSH suppression was greater in papillary cancer patients who were initially classified as being at higher risk for recurrence. This was not the case for follicular cancer patients, where TSH suppression was similar for all patients. For all stages of papillary cancer, a Cox proportional hazards model showed that disease stage, patient age, and radioiodine therapy all predicted disease progression, but TSH score category did not. However, TSH score category was an independent predictor of disease progression in high risk patients (p = 0.03), but was no longer significant when radioiodine therapy was included in the model (p = 0.09). There were too few patients with follicular cancer for multivariate analysis. These data suggest that physicians use greater degrees of TSH suppression in higher risk papillary cancer patients. Our data do not support the concept that greater degrees of TSH suppression are required to prevent disease progression in low-risk patients, but this possibility remains in high-risk patients. Additional studies with more patients and longer follow-up may provide the answer to this important question." @default.
• W2046987218 created "2016-06-24" @default.
• W2046987218 creator A5004522280 @default.
• W2046987218 creator A5012284384 @default.
• W2046987218 creator A5019086649 @default.
• W2046987218 creator A5019420130 @default.
• W2046987218 creator A5035163747 @default.
• W2046987218 creator A5035763597 @default.
• W2046987218 creator A5038090842 @default.
• W2046987218 creator A5042256960 @default.
• W2046987218 creator A5052714864 @default.
• W2046987218 creator A5056104537 @default.
• W2046987218 creator A5057366927 @default.
• W2046987218 creator A5062693491 @default.
• W2046987218 creator A5073085667 @default.
• W2046987218 creator A5074982883 @default.
• W2046987218 creator A5084622735 @default.
• W2046987218 date "1998-09-01" @default.
• W2046987218 modified "2023-09-22" @default.
• W2046987218 title "Thyrotropin Suppression and Disease Progression in Patients with Differentiated Thyroid Cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry" @default.
• W2046987218 cites W1548723165 @default.
• W2046987218 cites W2028080080 @default.
• W2046987218 cites W2092025017 @default.
• W2046987218 cites W2131206816 @default.
• W2046987218 cites W2335515807 @default.
• W2046987218 cites W4231013384 @default.
• W2046987218 cites W4241559836 @default.
• W2046987218 cites W4252217290 @default.
• W2046987218 cites W4252517469 @default.
• W2046987218 cites W4300226959 @default.
• W2046987218 doi "https://doi.org/10.1089/thy.1998.8.737" @default.
• W2046987218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9777742" @default.
• W2046987218 hasPublicationYear "1998" @default.
• W2046987218 type Work @default.
• W2046987218 sameAs 2046987218 @default.
• W2046987218 citedByCount "293" @default.
• W2046987218 countsByYear W20469872182012 @default.
• W2046987218 countsByYear W20469872182013 @default.
• W2046987218 countsByYear W20469872182014 @default.
• W2046987218 countsByYear W20469872182015 @default.
• W2046987218 countsByYear W20469872182016 @default.
• W2046987218 countsByYear W20469872182017 @default.
• W2046987218 countsByYear W20469872182018 @default.
• W2046987218 countsByYear W20469872182019 @default.
• W2046987218 countsByYear W20469872182020 @default.
• W2046987218 countsByYear W20469872182021 @default.
• W2046987218 countsByYear W20469872182022 @default.
• W2046987218 countsByYear W20469872182023 @default.
• W2046987218 crossrefType "journal-article" @default.
• W2046987218 hasAuthorship W2046987218A5004522280 @default.
• W2046987218 hasAuthorship W2046987218A5012284384 @default.
• W2046987218 hasAuthorship W2046987218A5019086649 @default.
• W2046987218 hasAuthorship W2046987218A5019420130 @default.
• W2046987218 hasAuthorship W2046987218A5035163747 @default.
• W2046987218 hasAuthorship W2046987218A5035763597 @default.
• W2046987218 hasAuthorship W2046987218A5038090842 @default.
• W2046987218 hasAuthorship W2046987218A5042256960 @default.
• W2046987218 hasAuthorship W2046987218A5052714864 @default.
• W2046987218 hasAuthorship W2046987218A5056104537 @default.
• W2046987218 hasAuthorship W2046987218A5057366927 @default.
• W2046987218 hasAuthorship W2046987218A5062693491 @default.
• W2046987218 hasAuthorship W2046987218A5073085667 @default.
• W2046987218 hasAuthorship W2046987218A5074982883 @default.
• W2046987218 hasAuthorship W2046987218A5084622735 @default.
• W2046987218 hasConcept C121608353 @default.
• W2046987218 hasConcept C126322002 @default.
• W2046987218 hasConcept C134018914 @default.
• W2046987218 hasConcept C143998085 @default.
• W2046987218 hasConcept C2777886399 @default.
• W2046987218 hasConcept C2779341817 @default.
• W2046987218 hasConcept C2779761222 @default.
• W2046987218 hasConcept C2781461381 @default.
• W2046987218 hasConcept C526584372 @default.
• W2046987218 hasConcept C71315377 @default.
• W2046987218 hasConcept C71924100 @default.
• W2046987218 hasConcept C72563966 @default.
• W2046987218 hasConcept C90924648 @default.
• W2046987218 hasConceptScore W2046987218C121608353 @default.
• W2046987218 hasConceptScore W2046987218C126322002 @default.
• W2046987218 hasConceptScore W2046987218C134018914 @default.
• W2046987218 hasConceptScore W2046987218C143998085 @default.
• W2046987218 hasConceptScore W2046987218C2777886399 @default.
• W2046987218 hasConceptScore W2046987218C2779341817 @default.
• W2046987218 hasConceptScore W2046987218C2779761222 @default.
• W2046987218 hasConceptScore W2046987218C2781461381 @default.
• W2046987218 hasConceptScore W2046987218C526584372 @default.
• W2046987218 hasConceptScore W2046987218C71315377 @default.
• W2046987218 hasConceptScore W2046987218C71924100 @default.
• W2046987218 hasConceptScore W2046987218C72563966 @default.
• W2046987218 hasConceptScore W2046987218C90924648 @default.
• W2046987218 hasIssue "9" @default.
• W2046987218 hasLocation W20469872181 @default.
• W2046987218 hasLocation W20469872182 @default.
• W2046987218 hasOpenAccess W2046987218 @default.
• W2046987218 hasPrimaryLocation W20469872181 @default.
• W2046987218 hasRelatedWork W2010645160 @default.
• W2046987218 hasRelatedWork W2020688170 @default.
• W2046987218 hasRelatedWork W2027938488 @default.

• next